Citations

Clear

16280 citation(s) found for "Yu, David".

The impact of neck tilt on the accuracy of deep learning generated contours for CT images of the head and neck
Harmsen, William S. , Tryggestad, E., Moseley, D , Brooks, Jamison , Routman, David, Tryggestad, Erik, Moseley, Douglas , Brooks, Jamison , Routman, David M.

Mayo Clinic

Journal of Applied Clinical Medical Physics | November 4, 2025 | Volume: 26 | Issue: 11 | Pages: No page available

10.1002/acm2.70316 | PMID 41183859 Get It

Abstract Background Deep learning auto segmentation (DLAS) tools are widely used for radiation therapy planning, yet limited information exists on how patient positioning impacts their performance, particularly in head and neck (HN) computed tomography (CT) imaging. Purpose This study investigates the impact of abnormal neck tilt on the accuracy of DLAS‐generated contours in HN CT scans. We hypothesize that abnormal positioning degrades auto segmentation performance, particularly for organs at risk (OARs) influenced by cervical spine orientation. Methods A total of 35 HN CT scans were retrospectively analyzed. Neck tilt was quantified using principal component analysis of the spinal cord contours from C1 to C4, with patients stratified into normal and abnormal tilt groups based on percentile thresholds. Seven FDA‐cleared DLAS tools were evaluated for OAR segmentation accuracy across brainstem, parotid glands, submandibular glands, brachial plexus, and optic nerves. Gold‐standard contours were curated from manually created clinical contours and compared to DLAS output using Sorenson's volumetric dice similarity coefficient (DSC), surface Dice similarity coefficient with a 2 mm threshold (sDSC), mean distance to agreement (MDA) and difference in mean dose. Statistical differences were assessed using Wilcoxon rank‐sum tests ( p < 0.05). Results Among the evaluated OARs, the parotid glands showed consistent and statistically significant degradation in contouring accuracy for patients with abnormal neck tilt across all metrics (DSC, sDSC, MDA) and across all seven DLAS tools. Changes in contouring accuracy resulted in significant differences in both absolute and signed difference in mean dose. No consistent differences were observed for other structures across multiple DLAS tools. Conclusions Abnormal neck tilt is associated with reduced DLAS accuracy and greater dose variability for parotid gland segmentation in HN radiotherapy planning. These findings underscore the need for enhanced patient quality assurance strategies for patients with abnormal positioning when using clinical DLAS workflows. Future work should explore automated detection of anatomical outliers and site‐specific model retraining to ensure accurate contouring delineation for patients with atypical positioning or anatomy.
Predictive modeling of long-term improvement in occlusion outcomes following Woven EndoBridge treatment of cerebral aneurysms: A machine learning approach
Karandish, Alireza , Essibayi, Muhammed Amir , Jabal, Mohamed Sobhi , Salim, Hamza , Musmar, Basel , Adeeb, Nimer , Dibas, Mahmoud , Li, Yan-Lin , Grist, James T. , Lay, Sovann V. , Guenego, Adrien , Renieri, Leonardo, Naamani, Kareem El, Möhlenbruch, Markus, Kral, Michael , Salem, Mohamed M , Foreman, Paul M. , Shaikh, Hamza , Župančić, Vedran , Ayberk, Gıyas , Rabinov, James D. , Maingard, Julian , Michelozzi, Caterina , Starke, Robert M., Ogilvie, Mark , Nguyên, Anh , Jones, Jesse , Brinjikji, Waleed , Nawka, Marie Teresa , Psychogios, Marios, Ulfert, Christian , Pukenas, Bryan , Burkhardt, Jan‐Karl , Slawski, Diana , Lubicz, Boris , Puri, Ajit S., Pero, Guglielmo , Raz, Eytan , Asadi, Hamed , Siddiqui, Adnan H. , Haranhalli, Neil , Ducruet, Andrew F. , Albuquerque, Felipe C , Regenhardt, Robert W. , Stapleton, Christopher J. , Kan, Peter , Kalousek, Vladimir , Lylyk, Pedro , Boddu, Srikanth , Knopman, Jared , Tjoumakaris, Stavropoula , Clarençon, Frédéric , Patel, Aman B. , Fuschi, Maurizio , Altschul, David , Investigators, for the WorldWideWEB, Salim, Hamza , Li, Yan-Lin , Algin, Oktay , Ghozy, Sherief , Guenego, Adrien , Shotar, Eimad , Lylyk, Ivan , Foreman, Paul M , Župančić, Vedran , Hafeez, Muhammad U , Ayberk, Giyas , Schirmer, Clemens M , Hassan, Ameer E , Nguyen, Anh , Jones, Jesse , Ulfert, Christian , Tawk, Rabih, Raz, Eytan , Griessenauer, Christoph J , Siddiqui, Adnan H , Levy, Elad I , Regenhardt, Robert W , Tjoumakaris, Stavropoula , Cuellar-Saenz, Hugo H , Jabbour, Pascal , Limbucci, Nicola , Altschul, David J , Dmytriw, Adam A , Dibas, Mahmoud , Pero, Guglielmo , Kalousek, Vladimir , Musmar, Basel , Essibayi, Muhammed Amir , Lay, Sovann V , Simonato, Davide , Zaccagna, Fulvio , Ghozy, Sherief , Renieri, Leonardo , Carnevale, Joseph Anthony , Saliou, Guillaume , Mastorakos, Panagiotis , Naamani, Kareem El, Shotar, Eimad , Möhlenbruch, Markus , Chung, Charlotte , Lylyk, Iván , Hafeez, Muhammad Ubaid , Catapano, Joshua S , Waqas, Muhammad , Kazancı, Atilla , Schirmer, Clemens M. , Piano, Mariangela , Kühn, Anna Luisa , Hassan, Ameer E , Psychogios, Marios‐Nikos , Huynh, Thien , Martinez-Gutierrez, Juan Carlos , Sheth, Sunil A , Tawk, Rabih G. , Pulli, Benjamin , Panni, Pietro , Puri, Ajit S , Griessenauer, Christoph J. , Levy, Elad I. , Cuellar, Hugo , Jabbour, Pascal , Limbucci, Nicola , Dmytriw, Adam A. , Investigators, for the WorldWideWEB

Mayo Clinic

Interventional Neuroradiology | November 3, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251391915 | PMID 41182964 Get It

Background The Woven EndoBridge (WEB) device represents an innovative solution for cerebral aneurysm occlusion, particularly for challenging wide-neck bifurcation aneurysms. However, factors affecting sustained occlusion remain poorly understood. We utilized machine learning to attempt to identify predictors of favorable long-term outcomes following WEB treatment. Methods In this multicenter retrospective study, we collected patient demographics, aneurysm characteristics, procedural details, and clinical outcomes. The primary endpoint was improvement in occlusion status, defined as maintained Raymond-Roy Occlusion Classification (RROC) grade 1, or improvement from grade 2 to 1, or from grade 3 to either 2 or 1 on final angiographic follow up. The dataset was split into training (75%) and validation (25%) sets. The CatBoost algorithm was selected based on performance metrics, with Shapley Additive exPlanations (SHAP) values calculated to determine feature importance. Furthermore, a multivariable binomial logistic regression model was performed to validate machine learning findings. Results Among 720 aneurysms from 36 hospitals, 84% showed improvement in occlusion at follow up. Both machine learning and multivariable logistic regression identified aneurysm height as the most consistent correlate of nonimprovement (odds ratio (OR) 0.90 per mm, p = 0.022). In the CatBoost model, the highest-ranking features by SHAP included aneurysm height, patient age, treatment acuity, ACom location, WEB-SLS device, bifurcation anatomy, aneurysm multiplicity, baseline modified Rankin Scale, access route, and partial thrombosis. Conclusions Machine-learning and regression analyses identified consistent predictors of occlusion improvement after WEB treatment, with aneurysm height most strongly linked to nonimprovement. These insights may guide patient selection and follow up. Findings require cautious interpretation and external validation in larger cohorts.
Burden of Central Nervous System Cancer in the United States, 1990-2021
Collaborators, GBD 2021 US CNS Cancer, Han, Hyun Jin , Kim, Yun Seo , Park, Seoyeon , Shin, Jae Il , Kim, Min Seo , Areda, Demelash, Tork, Mohammad Amin Bayat , Bilgin, Gokce Belge , Chennapragada, Suma Sri , Dean, Frances , Deekonda, Sindhura, Ding, Xueting, E’mar, Abdel Rahman, Elhadi, Muhammed, Fazeli, Patrick , Fisher, James L. , Fotouhi, Maryam , Gholamrezanezhad, Ali , Ida, Fidelia , Jani, Chinmay , Kalani, Rizwan , Kazemi, Foad , Keshwani, Ariz, Khosla, Atulya Aman , Lim, Stephen S , Murray, Christopher J L , Naik, Gurudatta , Nguyen, Dang Tuan , Penberthy, Louise, Pestell, Richard G. , Prabhu, Disha , Ramasamy, Shakthi Kumaran, Sabet, Cameron John, Şenol, Yiğit Can , Sham, Sunder, Solanki, Ranjan , Tanwar, Manoj , Amirikah, Mike Tuffour, Verma, Anjul, Yon, Dong Keon, Yon, Dong Keon , Shin, Jae I L , Senol, Yigit Can , Collaborators, GBD 2021 US CNS Cancer, Moon, Ju Hyung , Kim, Yong Bae , Ababneh, Hazim , Abu‐Zaid, Ahmed , Arul, Santhosh , Azzam, Ahmed Y , Bardhan, Mainak , Behnam, Babak , Bhardwaj, Prarthna V , Bhuyan, Soumitra Sudip , Lomer, Nima Broomand , Chen, Mengxuan , Dai, Xiaochen , Doshi, Ojas Prakashbhai , Fares, Jawad , Iwu, Chidozie Declan , Jalloh, Mohamed, Kankam, Samuel Berchi , Mehboob, Riffat , Meštrović, Tomislav , Mokdad, Ali H. , Natto, Zuhair S. , Nguyen, Dang, Nugen, Fred , Orscelik, Atakan , Parikh, Romil R , Puvvula, Jagadeesh , Ramasamy, Shakthi Kumaran, Sabet, Cameron John , Schumacher, Austin E , Sherchan, Samendra , Simegn, Gizeaddis Lamesgin , Singh, Jasvinder A. , Srichawla, Bahadar Singh , Taiba, Jabeen , Yunusa, Ismaeel , Zheng, David X. , Park, Keun Young

Mayo Clinic

JAMA Neurology | November 3, 2025 | Volume: 83 | Issue: 1 | Pages: 35

10.1001/jamaneurol.2025.4286 | PMID 41182787 Get It

Importance Primary brain and central nervous system cancer (collectively referred to as CNS cancer) comprises 2% of all human cancers and poses significant health and economic challenges in the United States. Objective To analyze CNS cancer burden in the US, stratified by time, location (state and division), sex, age group, and Sociodemographic Index (SDI). Design, Setting, and Participants This cross-sectional study involved a repeated analysis of Global Burden of Disease Study (GBD) 2021 data in 2024. Using data from 183 sources, CNS cancer metrics in the US were estimated across states and years. US CNS cancer metrics across all sexes and age groups were included in the GBD. Exposure CNS cancer diagnosis. Main Outcomes and Measures Overall and age-standardized estimates of the incidence, prevalence, mortality, disability-adjusted life-years (DALYs), years of life lost, and years lived with disability per 100 000 population, including 95% uncertainty intervals (UIs), and time trends. Results In 2021, for all age groups and sexes across the US, there were 31 780 incident cases (95% UI, 29971.1 to 32843.9). Age-standardized incidence, DALYs, and mortality rates per 100 000 population were 6.91 (95% UI, 6.58 to 7.12), 134.38 (95% UI, 129.83 to 137.95), and 4.1 (95% UI, 3.87 to 4.22), respectively. Despite no significant change observed in the overall incidence between 1990 and 2021, DALY and mortality rates decreased by 15.77% (95% UI, −17.75% to −13.68%) and 8.41% (95% UI, −11.09% to −6.22%), respectively. Substantial geographic variability was noted. Mississippi, Alabama, Kentucky, and Kansas (West North Central and East South Central divisions) and West Virginia faced persistently high burdens over the past 30 years. Sex differences were evident; disease burden was consistently higher in males compared with females. Age-specific estimates showed a bimodal distribution: the youngest group (&amp;lt;5 years) showed a significant decrease in incidence rate (−34.42% to −11.56%), whereas older age groups (&amp;gt;70 years) experienced increasing trends. DALYs and mortality rates were negatively correlated with SDI (ρ = −0.6860 and ρ = −0.6391; P &amp;lt; .001). Conclusions and Relevance These findings provide valuable insights into the CNS cancer burden across the US by age, sex, location, and SDI, enabling better public health status assessments, health care policy restructuring, and resource redistribution for improved care.
Abstract 4367364: A Multicenter Friedreich Ataxia Registry Identifies Posterior Wall Thickness as a Predictor of Major Adverse Cardiac Events
Dedio, Anna, McSweeney, K., Fournier, Anne , Yoon, Grace , Payne, R. Mark , Cripe, Linda , Patel, Aarti , Johnson, Jonathan N. , Lynch, David T. , Tate, Barbara , Feng, Yixuan , Mercer‐Rosa, Laura , Lin, Kimberly Y. , Niaz, Talha , McCormack, Shana Erin , Tate, Barbara, Feng, Yixuan, Huang, Jing Yang

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4367364 Get It

Background: Cardiac disease is the leading cause of premature mortality in Friedreich Ataxia (FA). However, validated prognostic indicators or early imaging biomarkers that can reliably predict cardiac events are lacking. To address this gap, we created a multicenter FA cardiac registry to characterize disease progression and identify early echocardiographic (echo) predictors of major adverse cardiac events (MACE). Methods: FA subjects from 6 North American centers with at least two echos performed ≥5 years apart were included. Demographics, FA-specific disease characteristics, and MACE (a composite of death, heart failure hospitalization, aborted sudden cardiac death, and/or life-threatening arrhythmia) were abstracted. Digital echo images were re-read at a centralized core lab. Paired T tests were utilized for comparison of the normally distributed first and second echo parameters, and logistic regression models were utilized to evaluate for predictors of MACE. Results: Of 115 subjects, 52 (45%) were female. Mean age at diagnosis was 10 ± 3 years, median GAA1 repeat length (a marker of genetic severity) was 700 (range 66–1200), and median age at first analyzed echo was 12 years (range 4-36). MACE occurred in 35 (30%) of the cohort. Serial echocardiograms demonstrated progressive worsening of multiple cardiac parameters over time, including markers of ventricular thickness and hypertrophy, chamber size, systolic function, and novel markers of atrial and ventricular strain (Table 1). On univariate analysis, several markers of hypertrophy and systolic function from the earliest analyzed echo predicted MACE. However, after adjusting for age of diagnosis, GAA1 repeat length, and collinearity among variables, only posterior wall thickness in diastole (PWTd) remained an independent predictor of MACE (odds ratio 1.8 per mm increase, 95% CI 1.1–3.3, p = 0.028). Conclusions: This multicenter FA registry identifies early posterior wall thickness as a significant and independent predictor of major adverse cardiac events in FA. Each millimeter increase in PWTd on early echo is associated with nearly double the odds of MACE. This commonly acquired parameter is often overlooked and may serve as a powerful early marker of cardiac risk. Further investigation of PWTd as a potential surrogate endpoint for therapeutic trials in FA is warranted.
Abstract 4366043: Kounis Syndrome: Keeping the heart Bee-zy!
G.V., Vishwajit, Dhanaraj, C Justin, Vijayakumar, Keerthika , MANIKANDAN, KANISHKA, Yashwanth, J., Ranjith, K, Vishwajit, G. V., MANIKANDAN, KANISHKA, K, Ranjith

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4366043 Get It

Background: Kounis syndrome (allergic angina syndrome) is triggered commonly by drugs, insect bites and even ice cream, causing myocardial infarction (MI). Treating this with the typical acute coronary syndrome (ACS) protocol may be clinically detrimental. We present a case of suspected type 2 Kounis syndrome in a low-resource setting. Case Description: A 45-year-old man presented to the emergency room with chest pain for the past 6 hours. He had history of multiple bee stings 14 hours ago. Review of systems was negative for rash, dizziness, palpitations or shortness of breath. He was a chronic smoker and alcoholic with no comorbidities and no history of allergies. He was conscious, oriented and his vitals were stable. ECG showed ST segment elevation in leads II, III and aVF (Figure 1). Echocardiogram showed mild left ventricular systolic dysfunction. Acute inferior wall MI and Kounis syndrome were suspected, and he was treated with routine ACS protocol, steroids and anti-histaminics. Coronary angiography showed mild, clinically insignificant atherosclerotic changes in the proximal right coronary artery (Figure 2), but absence of thrombus occluding the vessel. Patient was admitted in the cardiac intensive care unit and recovered well. Discussion: Common triggers for Kounis are antibiotics and insect bites. Insect venom contains phospholipase A2&5-HT, which can be allergic or directly toxic to cardiac tissue. They activate mast cells and induce vasospasm, leading to acute MI. Most patients present immediately with anaphylaxis and ACS, but some, like our patient, present with delayed, subclinical symptoms, presenting a diagnostic challenge. Tryptase and IgE levels as diagnostic tools are still under investigation considering the short half-life and lack of sensitivity respectively, and non-availability in low-resource settings. A therapeutic oxymoron has been described - the need for systemic vasoconstrictors and myocardial vasodilators. This warrants cautious use of beta blockers and epinephrine. The use of steroids and antihistaminics are under evaluation. A consensus is yet to be reached regarding diagnosis and treatment guidelines. Conclusion: Kounis syndrome must be considered high on differential in a case of acute MI if supporting history is positive. More research needs to be done on the long-term outcomes of the empiric treatment of suspected Kounis syndrome in low-resource settings, where advanced diagnostic tests are unavailable.
Abstract 4366812: Combined Efficacy, Safety, and Test Dose Tolerability of Etripamil for Acute Paroxysmal Supraventricular Tachycardia (PSVT) Across Multiple Clinical Trials
Piccini, Jonathan P. , Stambler, Bruce S. , Bharucha, David B. , Camm, Alan John , Ip, James E. , Noseworthy, Peter A. , Pokorney, Sean D. , Singh, Narendra

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4366812 Get It

Background: Etripamil nasal spray is a fast-acting, calcium channel blocker in development for the conversion of paroxysmal supraventricular tachycardia (PSVT) outside of a health-care setting. Studies have demonstrated the favorable safety and efficacy of self-administered etripamil in restoring sinus rhythm (SR) and reducing emergency department visits. Purpose: This report analyzes the efficacy, safety, and test-dose tolerability of etripamil across PSVT clinical studies. Methods: We systemically examined randomized, controlled and open-label trials evaluating etripamil in patients with PSVT. Efficacy measures included the proportion of patients converting from PSVT to SR within 30 minutes and the median times to conversion across all Phase 3 studies. Safety data for treatment-emergent adverse events (TEAEs), serious AEs, and test dose tolerability from Phase 2/3 studies were summarized descriptively. Results: NODE-1, NODE-301 Part 1, NODE-301 Part 2 (RAPID, including RAPID Extension, RAPID Open Label, RAPID Open Label Extension periods), NODE-302, and NODE-303 studies were analyzed (Table 1). The Kaplan-Meier estimate of etripamil exposed patients converting to SR within 30 minutes (n= 622) was 59.6% (range, 53.6% to 64.3%) with a median time to conversion of 18.5 minutes (95% CI, 15.7 to 21.0). The proportions of RCT placebo group patients converting from SVT to SR by 30 minutes ranged from 26.7% to 34.7%. Estimates of conversion of SVT to SR with etripamil at 60 minutes for individual studies ranged from 63.2% to 73.5% (Figure). Combined analysis showed mainly the occurrence of mild, transient TEAEs, primarily nasal discomfort, nasal congestion, rhinorrhea, throat irritation, and epistaxis (Table 2). 1,107 patients took at least one etripamil test dose while in SR; no significant change in average baseline heart rate or blood pressure was observed within 45 minutes of administration, and test dose failure occurred in only 16 patients (1.4%). Conclusions: Across multiple clinical studies of acute PSVT management, self-administered etripamil consistently demonstrated robust efficacy and a favorable safety profile for acute PSVT management. Safety data and the low rate of test dose failures indicate favorable tolerability, suggesting no need for a pretreatment test dose. These findings support the potential of etripamil as a patient-administered therapy for PSVT, which may reduce reliance on emergency care.
Abstract 4370874: A Suppression-and-Replacement Platform Identifies Pathogenic Variants in the LMNA- Encoded Lamin A/C Ig-Like Domain as Drivers of Nuclear Distortion and Aggregation
Huynh, Trung, Tester, David J. , Giudicessi, John R. , Ackerman, Michael J. , Kim, Changsung, Castrichini, Matteo

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4370874 Get It

Background: Pathogenic variants in LMNA -encoded lamin A/C cause a genetic cardiomyopathy marked by conduction disease, atrial and ventricular arrhythmias, and systolic dysfunction. The mechanisms underlying phenotypic differences between Ig-like and coiled-coil domain missense variants remains unclear. Here, we developed a novel suppression-and-replacement disease modeling (SupRep-DM) platform to screen LMNA missense variant function and prioritize mechanistically informative phenotypes. Methods: LMNA-SupRep-DM is a dual-component lentiviral system that enables simultaneous knockdown of endogenous LMNA via an LMNA -targeted shRNA and replacement with an shRNA-immune mutant lamin A cDNA encoding the pathogenic variant of interest with HA-tag. HEK293T cells and iPSC-derived cardiomyocytes (iPSC-CMs) were transduced with 9 unique SupRep-DM constructs harboring variants in either the coiled-coil (E82K, K97E, R216C, H222P, T224I, R335W) or Ig-like (R471H, R541C, R541H) domains. Cells were stained using HA-specific antibodies, imaged by confocal microscopy, and analyzed for nuclear morphology, aggregate burden, and fluorescence intensity. Statistics: Dunnett’s test and one-way ANOVA. Results: In HEK293T cells, 8/9 LMNA variants significantly reduced nuclear circularity (p< 0.05), most notably in K97E (-11%, n=89), R471H (-12%, n=62), and R541C (-9%, n=104). Additionally, K97E increased nuclear area (+24%) and R541C decreased it (−29%) vs wild-type (WT, p<0.0001). Lamin A intensity was significantly reduced in K97E, R471H, and R541C, but increased in T224I and R335W vs WT. In iPSC-CMs, Ig-fold variants R541C and R541H significantly reduced nuclear circularity (−28%, –34%), increased elongation (+42%, +49%), and elevated lamin A aggregates ~4–5-fold vs WT (p≤0.0005). R471H and the coiled-coil variant E82K also increased aggregate burden, while the remaining variants (K97E, R216C, H222P, T224I, R335W) showed no significant effects in iPSC-CMs. Conclusions: LMNA missense variants cause domain-specific nuclear disruptions, with variants localizing to the Ig-like domain inducing nuclear deformities and consistent aggregation across both cellular models. Coiled-coil variants showed more variable, context-dependent effects. The more pronounced phenotypes in iPSC-CMs may reflect contraction-mediated stress absent in HEK293T cells. The SupRep-DM platform sensitively detects these structural changes, demonstrating its utility for mechanistic prioritization of LMNA variants.
Abstract 4364440: Biogenic RYR2 Loss-of-Function Disrupts Intracellular Calcium Handling and Induces Electrical Remodeling in Re-Engineered Human Cardiomyocytes
Tester, David J. , Ye, Dan , Giudicessi, John, Giammarino, Lucilla , Giudicessi, John R. , Kim, Changsung, Ackerman, Michael

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4364440 Get It

Background: Calcium release channel deficiency syndrome (CRCDS) is caused by biogenic or biophysical loss-of-function (LOF) pathogenic variants in the RYR2 -encoded ryanodine receptor (RyR2), a key intracellular Ca 2+ release channel. Previously, we identified a novel homozygous duplication involving the promoter and exons 1-4 of RYR2 , leading to 80% RyR2 protein loss and exertion-related sudden death in the young. Here, we generated a RYR2 knockout (RYR2-KO) induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) model to explore intracellular and electrophysiological compensatory mechanisms that overcome this extreme loss of RyR2 protein. Methods: Using CRISPR/Cas9 gene editing, a homozygous c.163delT variant (p.S55Pfs*46) was inserted into a normal iPSC line (isogenic control) to create a homozygous RYR2-KO iPSC line. After re-engineering the lines into ventricular-like cardiomyocytes (iPSC-CMs), intracellular Ca 2+ handling was assessed by Fluo-4 AM cell imaging (0.5 Hz stimulation). Electrical remodeling in the L-type Ca 2+ current (I CaL ) was assessed using the whole-cell patch clamp technique. Results: Significant differences were observed in Ca 2+ transient parameters between RYR2-KO and isogenic control iPSC-CMs. Biogenic RyR2 loss significantly reduced Ca 2+ transient peak amplitude (CTA: 0.16 ± 0.01 ΔF/F0, p<0.0001) and upstroke velocity (CTV: 0.42 ± 0.06 (ΔF/F0)/t, p<0.0001), and prolonged Ca 2+ transient duration (CTD 90 : 1.59 ± 0.03 s, p=0.01) as compared to isogenic control (CTA: 0.48 ± 0.04 ΔF/F0; CTV: 1.30 ± 0.15 (ΔF/F0)/t; CTD 90 : 1.46 ± 0.05 s). Additionally, RyR2 loss abolished SR Ca 2+ leak (0.9 ± 0.9 % versus 35.1 ± 15.5 %, p=0.03). Lastly, a significant reduction in I CaL density was observed in RYR2-KO iPSC-CMs as compared to isogenic control iPSC-CMs (at 0 mV, RYR2-KO: -8.54 ± 1.60 pA/pF, control: -17.45 ± 3.69 pA/pF, p=0.0004). These data indicate that I CaL reduction may contribute to the reduced Ca 2+ transient peak. Conclusions: Complete loss of RyR2 in iPSC-CMs profoundly disrupts intracellular Ca 2+ handling, abolishes Ca 2+ sparks frequency, and secondarily down-regulates the sarcolemmal L-type Ca 2+ channel.
Abstract 4364400: DENND3-p.R534S Induces Electrophysiological Instability by Intracellular Calcium Mishandling in Cardiomyocytes
Gao, Shan , Tester, David J. , Giudicessi, John, Ackerman, Michael J. , Kim, Changsung, Giudicessi, John R.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4364400 Get It

Background: Previously, we discovered that DENND3, a guanine nucleotide exchange factor regulating Rab GTPases, influences cardiac ion channel trafficking. Both electrophysiological dysfunction and arrhythmic events were identified in variant inserted inducible pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) expressing DENND3-p.R534S. This was a novel missense variant identified in a patient with familial idiopathic ventricular fibrillation (IVF). Notably, augmented membrane retention of key cardiac ion channels was observed in both DENND3-p.R534S expressing TSA201 cells and variant inserted iPSC-CMs. To further study the mechanisms underlying arrhythmogenesis associated with IVF, intracellular calcium handling was characterized in these re-engineered heart cells with DENND3-p.R534S. Methods: Here, iPSC-CMs expressing DENND3-p.R534S and isogenic controls (IC) were studied. Optical action potentials were recorded using the FluoVolt voltage-sensitive dye at a constant pacing rate of 1 Hz. Multi-electrode array (MEA) recordings assessed beat period and conduction dynamics. Intracellular calcium dynamics were analyzed using Fluo-4 calcium imaging. Results: DENND3-p.R534S iPSC-CMs exhibited frequent arrhythmic activity, including irregular beating patterns (78%, n=28/36), alternans (25%), early afterdepolarizations (EADs, 8%), and delayed afterdepolarizations (DADs, 8%) versus 0% in IC lines (n=0/36, p<0.05). MEA recordings revealed significantly prolonged and irregular beat periods (2.59±0.26s vs. 1.37±0.10s, p<0.05), indicating electrical instability. Calcium imaging further showed significantly reduced calcium transient amplitude in DENND3-p.R534S iPSC-CMs compared to ICs (0.035±0.039ΔF/F 0 vs. 0.302±0.099ΔF/F 0 , p<0.05), and slowed upstroke velocity (0.170±0.212 ΔF/F 0 ●s -1 vs. 1.340±0.463ΔF/F 0 ●s -1 ) suggesting impaired intracellular calcium release. Conclusion: The DENND3-p.R534S variant not only disrupts ion channel distribution as shown previously but also markedly perturbs intracellular calcium handling, contributing to electrophysiological instability and arrhythmogenic cellular phenotypes. These findings highlight DENND3’s novel and emerging role in maintaining cardiac cellular homeostasis and rhythm stability.
Abstract 4359074: The Artificial Intelligence-Derived Electrocardiographic Age Gap is Associated with Adverse Clinical Outcomes in Cardiac Laminopathy
Tester, David J. , Friedman, Paul A. , Ackerman, Michael J. , Milone, Margherita , Giudicessi, John, Castrichini, Matteo , Sularz, Agata , Garmany, Ramin , Bos, J. Martijn , Attia, Zachi I. , Noseworthy, Peter A. , López-Jiménez, Francisco , Giudicessi, John R.

Mayo Clinic

Circulation | November 3, 2025 | Volume: 152 | Issue: Suppl_3 | Pages: No page available

10.1161/circ.152.suppl_3.4359074 Get It

Background: Disease-causative variants in LMNA -encoded lamin A/C cause the laminopathies, a heterogeneous group of diseases variably resulting in arrhythmogenic/dilated cardiomyopathy (ACM/DCM), lipodystrophy, muscular dystrophy, and progeria. The artificial intelligence (AI)-derived electrocardiographic age gap (AI-EAG), determined by the discrepancy between a patient’s artificial AI-enabled electrocardiogram (ECG) predicted biological age versus their chronological age, is accelerated in laminopathy. Thus, we sought to determine if the AI-EAG serves as a prognostic marker in patients with cardiac laminopathy. Methods: Retrospective analysis of 1,049 genotype-positive patients with genetic ACM/DCM was used to identify those with pathogenic/likely pathogenic (P/LP) variants in LMNA . After the exclusion of those who lacked a 12-lead ECG while in sinus rhythm, a previously trained AI-ECG age algorithm was used to determine the AI-EAG by subtracting the patient’s chronological age from the AI-ECG derived biological age. The AI-EAG was then correlated with a combined outcome of major ventricular arrhythmia [sudden cardiac arrest, sustained ventricular tachycardia, and appropriate implantable cardioverter-defibrillator shocks], heart transplantation, and cardiovascular death. Results: Overall, 147/1,049 (14%) patients with genetically-mediated ACM/DCM had a P/LP variant in LMNA . Of these, 80/147 (54%) LMNA variant-positive patients (52% female, mean chronological age 36 ± 15 years) had ECGs suitable for AI-EAG analysis. Most (52/80; 65%) had an AI-EAG >10 years with a mean AI-EAG of 17 ± 13 years. Of note, the AI-EAG was greater in those with a clinical cardiac phenotype (20 ± 14 vs. 13 ± 10 years; p = 0.011). As a continuous variable, an increased AI-EAG was associated with increased risk of the composite outcome at a median follow-up of 20 months (HR 1.036; 95% CI 1.004–1.068; p = 0.026) and AI-EAG > 10 and > 20 years were both associated with elevated risk (HR 4.272; 95% CI 1.388–13.147; p = 0.011 and HR 3.732; 95% CI 1.505–9.255; p = 0.004, respectively). Conclusion: In cardiac laminopathy, an increased AI-EAG was common and correlated with adverse cardiovascular outcomes. Non-invasive ascertainment of electrocardiographic aging by AI may provide a novel prognostic marker in cardiac laminopathy. Future studies are needed to validate this finding and further define the role of the AI-EAG in the risk-stratification of patients with cardiac laminopathy.